We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Higher Failure, Dropout Rates Foretell Decline in Drug Clinical Trials
Higher Failure, Dropout Rates Foretell Decline in Drug Clinical Trials
July 20, 2011
A steep decline in the number of products entering Phase III clinical trials, coupled with higher late-stage dropout rates and longer development times present a worrisome picture for pharmaceutical R&D, according to a new study.